COVID19 Vaccination Recruiting Phase Trials for Tozinameran (DB15696)

Also known as: COVID-19 Vaccination / COVID-19 immunisation / SARS-CoV-2 immunisation / COVID-19 immunization / SARS-CoV-2 immunization / Administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (procedure) / SARS-CoV-2 vaccination / Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)

IndicationStatusPhase
DBCOND0139286 (COVID19 Vaccination)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05315856Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms